What Brands Does Abbott Own?
1. Medical Devices (Largest revenue segment, strong growth)
- Diabetes Care – FreeStyle Libre™, Lingo™ (dominant in CGM market)
- Structural Heart – MitraClip™, Amplatzer™, TAVR devices
- Cardiac Rhythm Management – Pacemakers, defibrillators
- Vascular – Stents, closure devices
- Heart Failure – LVADs, remote monitoring
- Electrophysiology – Catheters, mapping systems
- Neuromodulation – Spinal cord, deep brain stimulators
2. Diagnostic Products (Pandemic-driven surge, still a key but declining segment)
- Rapid Diagnostics – BinaxNOW™, Panbio™ (COVID testing impact)
- Core Lab & Transfusion – Alinity™, ARCHITECT™
- Molecular Diagnostics – Alinity m™, PCR-based tests
- Point-of-Care – i-STAT™, ID NOW™
- Informatics & Automation – AlinIQ™, lab automation
3. Nutritional Products (Steady demand, strong brand presence)
- Infant Formula – Similac™, EleCare™ (hit by recall but recovering)
- Adult Nutrition – Ensure™, Glucerna™, PediaSure™
- Enteral Feeding – Jevity™, Nepro™
4. Established Pharmaceuticals (Branded generics, sold mostly outside U.S.)
- Gastroenterology – Creon™, Duphalac™
- Cardiovascular & Metabolic – Lipanthyl™, Synthroid™
- Pain & CNS – Brufen™, Serc™
- Women’s Health – Duphaston™, Femoston™
- Respiratory & Vaccines – Klaricid™, Influvac™
- Biosimilars – Oncology, women’s health